Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer

Background and objective Delta-Like1 (DLL1) can combine with Notch receptor and activate the Notch signal pathway, then made a decision to cell differentiation and regulate the development of many tissues. It is proved that DLL1 was highly correlated with tumor’growth and differentiation, our previo...

Full description

Bibliographic Details
Main Authors: Huanxin LIU, Juan PENG, Yifeng BAI, Linlang GUO
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.06.02
_version_ 1828862624376291328
author Huanxin LIU
Juan PENG
Yifeng BAI
Linlang GUO
author_facet Huanxin LIU
Juan PENG
Yifeng BAI
Linlang GUO
author_sort Huanxin LIU
collection DOAJ
description Background and objective Delta-Like1 (DLL1) can combine with Notch receptor and activate the Notch signal pathway, then made a decision to cell differentiation and regulate the development of many tissues. It is proved that DLL1 was highly correlated with tumor’growth and differentiation, our previously study showed that DLL1 was associated with MDR in small cell lung cancer (SCLC). The aim of this study is to furtherly investigate the role of DLL1 gene in small cell lung multi-drug resistance. Methods Firstly, the analysis of qRT-PCR and Western blot were used to study differential expression of DLL1 from mRNA and protein levels in both the H69 and H69AR cell lines. Then, we developed a stably DDL1 overexpressing H69AR-eGFP-DLL1 subline, by transfection with DLL1-pIRES2-EGFP. Moreover, the sensitivities of cells to chemotherapy drugs such as ADM, DDP, VP-16 were detected by CCK8 assay. The change of cell cycle and apoptosis rate were detected by flow cytometry. Results The expression of DLL1 was significantly decreased in H69AR cells than that in the H69 cells. The sensitivities of H69AR cells to chemotherapy drugs were increased when up-regulated the expression of DLL1, enforced DLL1 expression increased cell apoptosis and the cell cycle arrest in G0/G1 and S phase in H69AR cells, the expression of downstream genes HES1 and HEY1 were increased after transfected with DLL1-pIRES2-EGFP. Conclusion Our results suggest that overexpression of DLL1 in small cell lung cancer may increase the sensitivity of cells to chemotherapeutic agents. DLL1 influence drug resistance of small cell lung cancer through activating transcription of downstream genes HES1 and HEY1.
first_indexed 2024-12-13T03:28:05Z
format Article
id doaj.art-d2d6dfab8a464c71a97be1030b8f697b
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-13T03:28:05Z
publishDate 2013-06-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-d2d6dfab8a464c71a97be1030b8f697b2022-12-22T00:01:14ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872013-06-0116628228810.3779/j.issn.1009-3419.2013.06.02Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung CancerHuanxin LIUJuan PENGYifeng BAILinlang GUOBackground and objective Delta-Like1 (DLL1) can combine with Notch receptor and activate the Notch signal pathway, then made a decision to cell differentiation and regulate the development of many tissues. It is proved that DLL1 was highly correlated with tumor’growth and differentiation, our previously study showed that DLL1 was associated with MDR in small cell lung cancer (SCLC). The aim of this study is to furtherly investigate the role of DLL1 gene in small cell lung multi-drug resistance. Methods Firstly, the analysis of qRT-PCR and Western blot were used to study differential expression of DLL1 from mRNA and protein levels in both the H69 and H69AR cell lines. Then, we developed a stably DDL1 overexpressing H69AR-eGFP-DLL1 subline, by transfection with DLL1-pIRES2-EGFP. Moreover, the sensitivities of cells to chemotherapy drugs such as ADM, DDP, VP-16 were detected by CCK8 assay. The change of cell cycle and apoptosis rate were detected by flow cytometry. Results The expression of DLL1 was significantly decreased in H69AR cells than that in the H69 cells. The sensitivities of H69AR cells to chemotherapy drugs were increased when up-regulated the expression of DLL1, enforced DLL1 expression increased cell apoptosis and the cell cycle arrest in G0/G1 and S phase in H69AR cells, the expression of downstream genes HES1 and HEY1 were increased after transfected with DLL1-pIRES2-EGFP. Conclusion Our results suggest that overexpression of DLL1 in small cell lung cancer may increase the sensitivity of cells to chemotherapeutic agents. DLL1 influence drug resistance of small cell lung cancer through activating transcription of downstream genes HES1 and HEY1.http://dx.doi.org/10.3779/j.issn.1009-3419.2013.06.02Delta-Like1 (DLL1)Mul-tidrug resistanceLung neoplasms
spellingShingle Huanxin LIU
Juan PENG
Yifeng BAI
Linlang GUO
Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
Chinese Journal of Lung Cancer
Delta-Like1 (DLL1)
Mul-tidrug resistance
Lung neoplasms
title Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
title_full Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
title_fullStr Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
title_full_unstemmed Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
title_short Up-regulation of DLL1 May Promote the Chemotherapeutic Sensitivity 
in Small Cell Lung Cancer
title_sort up regulation of dll1 may promote the chemotherapeutic sensitivity 
in small cell lung cancer
topic Delta-Like1 (DLL1)
Mul-tidrug resistance
Lung neoplasms
url http://dx.doi.org/10.3779/j.issn.1009-3419.2013.06.02
work_keys_str_mv AT huanxinliu upregulationofdll1maypromotethechemotherapeuticsensitivityinsmallcelllungcancer
AT juanpeng upregulationofdll1maypromotethechemotherapeuticsensitivityinsmallcelllungcancer
AT yifengbai upregulationofdll1maypromotethechemotherapeuticsensitivityinsmallcelllungcancer
AT linlangguo upregulationofdll1maypromotethechemotherapeuticsensitivityinsmallcelllungcancer